David F. Tang-Wai, MD

University of Toronto, Toronto, Ontario, Canada; Krembil Brain Institute, Toronto Western Hospital, Toronto Ontario, Canada; University Health Network Memory Clinic, Toronto Western Hospital, Toronto, Ontario, Canada

  • 2Articles
  • 1.9KReads1
  • 2025–2026Active
  • 29Collaborators
  • 2Citations2

1 Read counts for articles published before 2020 may include some non-human traffic.

2 Citation counts provided by Crossref.

About

David F. Tang-Wai, MD, is affiliated with the University of Toronto, Krembil Brain Institute, and University Health Network Memory Clinic in Toronto, Ontario, Canada. His publications focus on cognition, geriatric psychiatry, addiction, and Alzheimer disease, including studies on neuropsychiatric symptom clusters and brain structure in Alzheimer disease and the effects of alcohol use on cognition in individuals with neurocognitive disorders. He has collaborated frequently with Sanjeev Kumar, Agessandro Abrahao, Angela Roberts, Angela Troyer, and Anthony Lang.

Publications

JCP
Neuropsychiatric Symptom Clusters and Brain Structure in Alzheimer’s Disease
Original Research

Neuropsychiatric Symptom Clusters and Brain Structure in Alzheimer’s Disease

March 16, 2026

Neuropsychiatric symptoms in Alzheimer’s disease separate into hyperactivity, psychosis, neurovegetative, and affective clusters, supporting a cluster-based paradigm linking behavioral symptoms with brain structure and functional decline.
, , , et al
JCP
Effects of Alcohol Use on Cognition in Individuals With Neurocognitive Disorders
Original Research

Effects of Alcohol Use on Cognition in Individuals With Neurocognitive Disorders

August 6, 2025

In a memory clinic cohort of patients with neurocognitive disorders, alcohol related cognitive impairment resulted in specific deficits involving cognitive control during delayed recall task.
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Ketamine and Psychedelics

Listen to the Podcast
The Journal of Clinical Psychiatry podcast cover with Benjamin Brody, MD

Subscribe to read
more articles

Subscribe